Delivery Order SPE2DB24D2101-SPE2DB25FKLZZ
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PARSABIV 2.5 MG/0.5 ML VIAL 0.5ML, a medical product. The $5,884.20 contract has a firm fixed price and an ultimate completion date of July 29, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical...
- This is a $1,176.84 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PARSABIV 2.5 MG/0.5 ML VIAL 0.5ML, a medical product, with a performance period through June 20, 2025. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PARSABIV 2.5 MG/0.5 ML VIAL 0.5ML, a pharmaceutical product, with a ceiling value of $1,176.84 and a completion date of July 24, 2025. The contract is a firm-fixed-price delivery order, and it is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract, valued at $2,687.95, is for the supply of the pharmaceutical product PARSABIV 2.5 MG/0.5 ML VIAL 0.5ML. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp,...
- This is a $3,530.52 firm fixed-price delivery order federal contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PARSABIV 2.5 MG/0.5 ML VIAL 0.5ML, a specialty medication, with a period of performance through March 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for the supply of PARSABIV 2.5 MG/0.5 ML VIAL 0.5ML. The contract has a ceiling value of $2,687.95 and a completion date of June 27, 2024. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a subsidiary of AmerisourceBergen Corporation, to supply PARSABIV 2.5 MG/0.5 ML VIAL 0.5ML, a pharmaceutical product. The contract is a firm fixed price delivery order with a ceiling value of $2,687.95 and a performance period through April 10, 2024. AmerisourceBergen Drug Corp, as the prime contractor, is not subject to any set-aside requirements for this award....
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $2,150.36 order is for the pharmaceutical product PARSABIV 2.5 MG/0.5 ML VIAL 0.5ML, with a completion date of March 15, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,561.70 firm fixed-price delivery order contract is for the medical product "PARSABIV 2.5 MG/0.5 ML VIAL 0.5ML" and has an ultimate completion date of January 15, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $2,638.42 firm fixed price delivery order is for the supply of 4.5 gram vials of the antibiotic Piperacil-Tazobact. The contract is non-set-aside and has an ultimate completion date of July 10, 2025. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKLZZDelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,353.68, is for the delivery of the pharmaceutical product PARSABIV 2.5 MG/0.5 ML VIAL 0.5ML. The contract has a period of performance through July 25, 2025 and is a firm fixed-price delivery order. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp is the prime contractor and will be responsible for supplying the requested pharmaceutical product to support military and government healthcare programs. As a significant supplier to the DLA, Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the agency to provide a comprehensive range of pharmaceutical products and medical supplies worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 7/3/25 |